Aptus Pharma Limited Hits Lower Circuit for the 2nd Straight Session on BSE, 25 September 2026

On 25 September 2026, Aptus Pharma Limited (APPL) hit the lower circuit on BSE at Rs 341.05, a 2% negative move from the previous close of Rs 348. The company’s market cap stood at Rs 596.82 crore. The lower circuit price for the session was Rs 341.05.

The move was driven by selling pressure against the exchange-defined price band. At the time of writing the stock was locked at its lower circuit level, which makes the session worth noting for short-term market participants.

Key Takeaways

• Aptus Pharma Limited (APPL) hit the lower circuit on BSE at Rs 341.05 on 25 September 2026.
• The session move was -2% against a previous close of Rs 348.
• Market capitalisation stood at Rs 596.82 crore with a PE ratio of 129.18.
• This is the 2nd straight session at the lower circuit, with the run starting on 24 September 2026.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

All figures above are as of 25 September 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Aptus Pharma Limited opened at Rs 341.05 on BSE, compared with a previous close of Rs 348. During the session, the stock traded between Rs 341.05 and Rs 341.05 before touching the lower circuit price of Rs 341.05.

The absolute day change was Rs 6.95, while the percentage move was -2%. The event figures are kept to a single exchange so the numbers stay comparable.

The selected exchange matters because price bands, day range and previous-close values can differ across exchanges. This article uses BSE consistently for the event table and narrative. The stated lower circuit limit for the session was Rs 341.05, which is the level the price reached.

The Lower Circuit Streak So Far

This is session 2 of an unbroken run for Aptus Pharma Limited. The streak began on 24 September 2026, from a base price of Rs 354.1. Across the run the stock has moved -3.69% in total.

A repeated lower circuit matters more than a single one. It says the order book has stayed one-sided across multiple sessions rather than reacting to a single day of news, and for anyone holding the stock it means the price on screen has been hard to trade at for several days running.

This page is the running record for the streak and is updated each session rather than being replaced by a fresh article. That keeps one address for the event instead of splitting the same story across competing pages.

Why Aptus Pharma Limited Hit Lower Circuit

Aptus Pharma Limited hit the lower circuit after selling pressure pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.

Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.

Within the session the stock reached the lower circuit level of Rs 341.05.

What the Lower Circuit Means

A lower circuit is the minimum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For Aptus Pharma Limited, the captured lower circuit price was Rs 341.05 on 25 September 2026.

The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the lower circuit explains what happened in the session and where the price band was reached.

Aptus Pharma Limited Fundamentals and Valuation

Available market data gives a fuller picture than price action alone. For Aptus Pharma Limited, PE ratio was 129.18, PB ratio was 17.74, book value was Rs 19.61, EPS was 2.69, ROE was 30.48%, ROCE was 30.01%, dividend yield was 0% and debt-to-assets ratio was 0.31, on a market cap of Rs 596.82 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.

At the reported PB ratio of 17.74, the market valued Aptus Pharma Limited above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

For investors tracking lower circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.

Peer and Sector Context

Aptus Pharma Limited belongs to the Trading industry. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Several of these peers are far larger by market capitalisation than Aptus Pharma Limited. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Aptus Pharma Limited’s PE ratio was 129.18, compared with an available peer PE average of 82.45, calculated from the 5 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 69.29, the 50-day moving average was 326.73 and the 200-day moving average was 220.28.

Worth flagging: the RSI reading sits on the opposite side of neutral to the day move and the last traded price and the 50-day average point in different directions. Indicator values in the dataset can lag the live session, so they should be checked against a live chart before being relied on.

What Readers Should Know

The main confirmed fact is that Aptus Pharma Limited hit the lower circuit on BSE at Rs 341.05 on 25 September 2026, with a -2% day move.

The practical limitation after a lower-circuit session is execution. Sellers queue at the band with few buyers, so exiting at the quoted price may not be possible. The other limitation is that no official catalyst was confirmed at the time of writing.

Readers should treat lower circuit events as market updates, not standalone investment conclusions. The price band shows heavy near-term selling pressure, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.

Frequently Asked Questions

Why did Aptus Pharma Limited hit lower circuit on 25 September 2026?

The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

How many sessions has Aptus Pharma Limited hit lower circuit in a row?

This is session 2 of the current run, which began on 24 September 2026. This page is updated each session rather than replaced with a new article.

What was APPL share price on 25 September 2026?

The last traded price used in this article was Rs 341.05 on BSE. That price matched the lower circuit price captured for the event.

What was the lower circuit price for APPL?

The lower circuit price was Rs 341.05. The stated exchange lower circuit limit was Rs 341.05. The event numbers in this article are aligned to BSE.

What is Aptus Pharma Limited’s market cap and PE ratio?

Aptus Pharma Limited’s market cap was Rs 596.82 crore. PE ratio was 129.18.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 25 September 2026.

Does hitting a lower circuit mean Aptus Pharma Limited is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Aptus Pharma Limited shares when the stock is at the lower circuit?

It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.

What happens the next trading session after a lower circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the lower circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Aptus Pharma Limited the stated limit was Rs 341.05. For this session, Aptus Pharma Limited moved -2%.

Footer Disclosure